Front Row Seat: Can We Talk about the Cure? A Conversation with Dr. Eric Winer
For decades, stage IV meant managing the disease — not beating it. That story is beginning to change.
In this episode of Live from Stage IV, Victoria Goldberg sits down with Dr. Eric Winer — oncologist, director of the Yale Cancer Center, and former president of ASCO — to ask a question that once felt impossible: Can we cure metastatic breast cancer?
Dr. Winer walks through the landmark trials reshaping HER2-positive treatment, introduces the concept of "curative hope," and gets into what's hardest about ER-positive and triple-negative disease, cancer dormancy, the science of exercise, and bold new trial designs like SAFFO and HORIZON that are rewriting the playbook.
Front Row Seat: The Enigma of the Blood-Brain Barrier & More with Dr. Nancy Lin
Dr. Nancy Lin of Dana-Farber Cancer Institute joins us to talk about one of the most complex challenges in metastatic breast cancer: when it spreads to the brain. She walks us through the newest treatments, the latest trial data, and the biology of the blood-brain barrier — why it blocks most drugs, and how researchers are finally learning to work around it.
Front Row: SABCS 2025 Insights with Dr. Francisco Esteva
Join host Victoria Goldberg and Dr. Francisco Esteva as they break down the groundbreaking research from the San Antonio Breast Cancer Symposium 2025. Discover the latest advances in metastatic breast cancer treatment, including new first-line therapies for HER2-positive disease with 40-month progression-free survival, oral SERDs revolutionizing hormone receptor-positive treatment, and antibody drug conjugates transforming triple-negative breast cancer care. Dr. Esteva shares expert insights on brain metastasis prevention, liquid biopsy-guided therapy switching, and how artificial intelligence is reshaping oncology. Whether you're a patient, caregiver, or healthcare professional, this episode offers hope and practical information about the cutting-edge treatments available in 2026.
Fighting for Patients: Dr. Rebecca Shatsky on Insurance, Burnout, and Hope in MBC
Dr. Rebecca Shatsky, Director of Breast Medical Oncology at UC San Diego, shares her experiences fighting for patients with breast cancer. In this episode, Dr. Shatsky discusses the growing challenges clinicians face—from insurance denials and funding cuts to the emotional toll of burnout and the spread of cancer misinformation.
Hear real stories about advocating for life-saving treatments, navigating the complexities of clinical trials, and the importance of patient empowerment. Dr. Shatsky also offers hope, highlighting the latest breakthroughs in metastatic breast cancer research and the progress being made in treatment options.
Whether you’re a patient, caregiver, or healthcare professional, this episode delivers candid insights, practical advice, and a message of resilience and hope in the face of adversity.
Podcasters Roundtable: Samira Daswani, Host of The Patient from Hell
In this episode, hosts Victoria Goldberg and Abigail Johnston sit down with Samira Daswani, host of "The Patient From Hell" podcast, for a candid and insightful conversation about patient advocacy, storytelling, and the evolving landscape of cancer care. Samira shares her path from reluctant podcast guest to passionate host, highlighting the importance of amplifying patient voices and democratizing information for those navigating cancer diagnoses—especially in communities where open discussion is rare.
The discussion delves into the challenges of reaching diverse audiences, the power of authentic, minimally edited conversations, and the need for both scientific and personal perspectives in patient-centered content. The trio reflects on the shifting attitudes in cancer communities, the critical role of support networks, and the ongoing mission to educate and empower patients worldwide. The episode wraps up with ideas for future collaborations and a shared commitment to making a meaningful impact through storytelling and advocacy.
Live Chat: SERD Surge with Dr. Sherry Shen
Host Victoria, with Dr. Sherry Shen and co-host Ellen, delivers a concise, patient-focused overview of oral SERDs in HR+ metastatic breast cancer—covering ESR1 mutations, key trials (evERA, SERENA‑6), FDA‑approved agents, side-effect management, and treatment implications. This is the first episode in our Live Chats series. Bonus clip: Rebecca Shatsky, MD, previews the evERA trial and her excitement about combining capivasertib with oral SERDs.